| Announce Date | 11/05/2025 |
| EPS Normalized Actual | $-1.99633 (Miss by $-2.12633) |
| EPS GAAP Actual | $-1.99633 (Miss by $-2.12633) |
| Revenue Actual | $0.533B |
| Revenue Surprise | Beat by $533M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $0.17216 |
| EPS GAAP Estimate | $0.17216 |
| Revenue Estimate | $0.9744031B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2026 | 0.28401 | 5.63 | 0.28002 | 0.28815 | 1 |
| Dec 2025 | 0.39 | 4.1 | 0.39 | 0.39 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 2.06 | 1.89284 | 0.533B | -4.13% | -325.89M |
| FQ2 2025 (Jun 2025) | -2.03 | -2.03 | 0.528B | -1.89% | 528M |
| FQ1 2025 (Mar 2025) | -0.05 | -0.05 | 0.548B | -2.01% | 548M |
| FQ4 2024 (Dec 2024) | 0.0531 | 0.0531 | 0.68B | -41.18% | 680M |
| FQ3 2024 (Sep 2024) | -0.14 | -0.14 | 0.555B | -46.49% | 555M |
| FQ4 2017 (Dec 2017) | 481.73 | 481.73 | 0.654B | 100% | 654M |
| FQ4 2018 (Dec 2018) | 143.36 | 143.36 | 0.651B | -0.46% | 651M |
| FQ1 2020 (Mar 2020) | -170.5 | -170.5 | 0.693B | 100% | 693M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
0.17216
Consensus Revenue Estimates
0.9744031B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.28774 | -- | 0.28376 | 0.29586 | 1 |
| FQ3 2027 (Sep 2027) | 0.14461 | -- | 0.14329 | 0.14559 | 1 |
| FQ2 2027 (Jun 2027) | 0.14251 | -- | 0.14121 | 0.14348 | 1 |
| FQ1 2027 (Mar 2027) | 0.13757 | -- | 0.13567 | 0.14145 | 1 |
| FQ4 2026 (Oct 2026) | 0.19031 | -- | 0.18508 | 0.19712 | 1 |
| FQ3 2026 (Jul 2026) | 0.18213 | -1031.06 | 0.17713 | 0.18864 | 1 |
| FQ2 2026 (Jun 2026) | 0.17463 | 1262.46 | 0.17133 | 0.17725 | 1 |
| FQ1 2026 (Mar 2026) | 0.17216 | 129.04 | 0.1689 | 0.17475 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.73B | -- | 0.72B | 0.75B | 2 |
| FQ3 2027 (Sep 2027) | 0.62B | -- | 0.61B | 0.62B | 2 |
| FQ2 2027 (Jun 2027) | 0.58B | -- | 0.57B | 0.58B | 2 |
| FQ1 2027 (Mar 2027) | 0.58B | -- | 0.58B | 0.59B | 2 |
| FQ4 2026 (Oct 2026) | 0.9B | -- | 0.88B | 0.92B | 2 |
| FQ3 2026 (Jul 2026) | 0.9B | 40.59 | 0.88B | 0.92B | 2 |
| FQ2 2026 (Jun 2026) | 0.95B | 44.45 | 0.94B | 0.96B | 4 |
| FQ1 2026 (Mar 2026) | 0.97B | 43.76 | 0.96B | 0.99B | 4 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
4
EPS # of Misses
4
EPS # of in-lines
0
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.16716 | 2.06 | 1.89284 | 91.89% |
| FQ2 2025 (Jun 2025) | -2.03 | -2.03 | 100% | |
| FQ1 2025 (Mar 2025) | -0.05 | -0.05 | 100% | |
| FQ4 2024 (Dec 2024) | 0.0531 | 0.0531 | 100% | |
| FQ3 2024 (Sep 2024) | -0.14 | -0.14 | 100% | |
| FQ4 2017 (Dec 2017) | 481.73 | 481.73 | 100% | |
| FQ4 2018 (Dec 2018) | 143.36 | 143.36 | 100% | |
| FQ1 2020 (Mar 2020) | -170.5 | -170.5 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0.86B | $0.53B | $-325.89M | -61.14% |
| FQ2 2025 (Jun 2025) | $0B | $0.53B | $528M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $0.55B | $548M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $0.68B | $680M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $0.56B | $555M | 100% |
| FQ4 2017 (Dec 2017) | $0B | $0.65B | $654M | 100% |
| FQ4 2018 (Dec 2018) | $0B | $0.65B | $651M | 100% |
| FQ1 2020 (Mar 2020) | $0B | $0.69B | $693M | 100% |